Thermosensitive citrate-based mussel-inspired attack-defense integrated bioadhesives facilitate complicated wound healing.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41625490.
- Also identified by DOI 10.1016/j.bioactmat.2026.01.010 and PMC identifier 12857384.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The treatment of complicated wounds remains unsatisfactory due to the lack of a comprehensive strategy synchronously addressing concomitant disease cure along with favorable wound healing. Herein, a family of thermosensitive citrate-based mussel-inspired bioadhesives (TCMBAs) were developed for the first time by mixing poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol)-incorporated and calcium-containing water-soluble injectable citrate-based mussel-inspired bioadhesive prepolymer with FeCl<sub>3</sub> in bicine solution. With a tunable minimum sol-to-gel transition temperature in the range of 28-42 °C, the optimized TCMBAs can be conveniently administrated at room temperature and instantly close wounds at body temperature. TCMBAs exhibit a suite of ideal material properties, including high wet tissue adhesion strength, rapid shape adaptability, self-healing capability, and high elasticity. Furthermore, they demonstrate fast biodegradability, excellent biocompatibility, and potent hemostatic ability. The intrinsic photothermal conversion efficiency of TCMBAs facilitates mild photothermal therapy (PTT), inducing a thermo-mediated cytotoxic effect that effectively eliminates both pathogenic bacteria and cancer cells. This multifunctional "attack-defense" property, combining antimicrobial and antitumor effects with barrier protection and regenerative functions, was demonstrated in infected and cancerous wound models. TCMBA-based treatment under NIR irradiation promoted healing of infected wounds and suppressed tumor recurrence and metastasis while accelerating wound closure. These results highlight TCMBAs as a highly promising platform for the treatment of complex and refractory wounds.